SCOPUS 정보 검색 플랫폼

Scandinavian Journal of Rheumatology

Volumn 31, Issue 4, 2002, Pages 230-238

A placebo and active comparator-controlled trial of rofecoxib for the treatment of rheumatoid arthritis

(9) Geusens, P P a Truitt, K a Sfikakis, P a Zhao, P L a DeTora, Lisa a Shingo, S a Lau, C S a Kalla, A a Tate, G a

a MERCK RESEARCH LABORATORIES (United States)

Author keywords

COX 2; Naproxen; NSAID; RA; Randomized trial; Rofecoxib

Indexed keywords

CYCLOOXYGENASE 2 INHIBITOR; NAPROXEN; NONSTEROID ANTIINFLAMMATORY AGENT; PLACEBO; ROFECOXIB;

ABDOMINAL PAIN; ADULT; ARTHRITIS; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DEPRESSION; DIARRHEA; DIGESTIVE SYSTEM PERFORATION; DIGESTIVE SYSTEM ULCER; DISEASE ACTIVITY; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG SAFETY; DRUG TOLERABILITY; DYSPEPSIA; EDEMA; EPIGASTRIC PAIN; FACE PAIN; FEMALE; GASTROINTESTINAL HEMORRHAGE; HEADACHE; HEARTBURN; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALAISE; MALE; MIGRAINE; MULTICENTER STUDY; NAUSEA; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RENOVASCULAR HYPERTENSION; RHEUMATOID ARTHRITIS; STATISTICAL ANALYSIS; URTICARIA; VISUAL DISORDER;

ADULT; AGED; ARTHRITIS, RHEUMATOID; CYCLOOXYGENASE 2; CYCLOOXYGENASE 2 INHIBITORS; CYCLOOXYGENASE INHIBITORS; DOUBLE-BLIND METHOD; FEMALE; HUMANS; ISOENZYMES; JOINTS; LACTONES; MALE; MEMBRANE PROTEINS; MIDDLE AGED; NAPROXEN; PLACEBOS; PROSTAGLANDIN-ENDOPEROXIDE SYNTHASES; SULFONES; TREATMENT OUTCOME;

EID: 0036351504 PISSN: 03009742 EISSN: None Source Type: Journal
DOI: 10.1080/030097402320318431 Document Type: Article

Times cited : (40)

References (26)

1
- 0001023001
- Interpreting the clinical significance of the differential inhibition of cyclooxygenase-1 and cyclooxygenase-2
- (1999) Rheumatol , vol.38 , pp. 779-788
- Brooks, P.¹ Emery, P.² Evans, J.F.³ Fenner, H.⁴ Hawkey, C.J.⁵ Patrono, C.⁶

2
- 0033064312
- Characterization of rofecoxib as a cyclooxygenase-2 isoform inhibitor and demonstration of analgesia in the dental pain model
- (1999) Clin Pharmacol Ther , vol.65 , Issue.3 , pp. 336-347
- Ehrich, E.W.¹ Dallob, A.² De Lepeleire, I.³ Van Hecken, A.⁴ Riendeau, D.⁵ Yuan, W.⁶

3
- 0035219921
- Efficacy of single-dose and multidose rofecoxib in the treatment of post-orthopedic surgery pain
- (2001) Am J Orthop , pp. 40-48
- Reicin, A.¹ Brown, J.² Jove, M.³ DeAndrade, J.R.⁴ Bourne, M.K.D.⁵ Walters, D.⁶

4
- 0032744460
- The safety profile, tolerability, and effective dose range of rofecoxib in the treatment of rheumatoid arthritis
- (1999) Clin Ther , vol.21 , pp. 1688-1702
- Schnitzer, T.J.¹ Truitt, K.² Fleischmann, R.³ Dalgin, P.⁴ Block, J.⁵ Zeng, Q.⁶

5
- 0034546509
- Rofecoxib, a new cyclooxygenase 2 inhibitor shows sustained efficacy, comparable with other nonsteroidal anti-inflammatory drugs: A 6-week and a 1-year trial in patients with osteoarthritis
- (2000) Arch Fam Med , vol.9 , pp. 1124-1134
- Saag, K.¹ Van der Heijde, D.² Fisher, C.³ Samara, A.⁴ DeTora, L.⁵ Bolognese, J.⁶ Sperling, R.⁷

6
- 0033601079
- Adverse upper gastrointestinal effects of rofecoxib compared with NSAIDS
- (1999) JAMA , vol.282 , pp. 1929-1933
- Langman, M.J.¹ Jensen, D.M.² Watson, D.J.³ Harper, E.S.⁴ Zhoa, P.L.⁵ Quan, H.⁶

7
- 0034707105
- Comparison of upper gastrointestinal toxicity of rofecoxib and naproxen in patients with rheumatoid arthritis
- (2000) N Eng J Med , vol.343 , pp. 1520-1528
- Bombardier, C.¹ Laine, L.² Reicin, A.³ Shapiro, D.⁴ Burgos-Vargas, R.⁵ Davis, B.⁶

8
- 0030000725
- Guidelines for monitoring drug therapy in rheumatoid arthritis
- (1996) Arthritis Rheum , vol.39 , pp. 723-731

9
- 0029985217
- Guidelines for the management of rheumatoid arthritis
- (1996) Arthritis Rheum , vol.39 , pp. 713-722

10
- 0025953518
- Nonsteroidal anti-inflammatory drug-associated gastropathy: Incidence and risk factor models
- (1991) Am J Med , vol.91 , pp. 213-222
- Fries, J.F.¹ Williams, C.A.² Bloch, D.A.³ Michel, B.A.⁴

11
- 0027786841
- The relative toxicity of alternative therapies for rheumatoid arthritis: Implications for the therapeutic progression
- (1993) Semin Arthritis Rheum , vol.23 , Issue.2 SUPPL. 1 , pp. 68-73
- Fries, J.F.¹ Williams, C.A.² Ramey, D.R.³ Bloch, D.A.⁴

12
- 0029044362
- American College of Rheumatology preliminary definition of improvement in rheumatoid arthritis
- (1995) Arthritis Rheum , vol.38 , pp. 727-735
- Felson, D.T.¹ Anderson, J.J.² Boers, M.³ Bombardier, C.⁴ Furst, D.⁵ Goldsmith, C.⁶

13
- 0003792032
- Human Medicines Evaluation Unit. European Agency for the Evaluation of Medicinal Products. December
- (1998) Points to consider on clinical investigation of slow-acting anti-rheumatic medicinal products in rheumatoid arthritis

14
- 0004143421
- U.S. Department of Health and Human Services Public Health Service. Food and Drug Administration. April
- (1988) Guidelines for the clinical evaluation of anti-inflammatory and antirheumatic drugs (adults and children)

15
- 0033843672
- Upper gastrointestinal tolerability of celecoxib, a cox-2 specific inhibitor, compared to naproxen and placebo
- (2000) J Rheumatol , vol.27 , pp. 1876-1883
- Bensen, W.G.¹ Zhao, S.Z.² Burke, T.A.³ Zabinski, A.R.⁴ Makuch, R.W.⁵ Maurath, C.J.⁶

16
- 0035079023
- Renal Effects of COX-2-selective inhibitors
- (2001) Am J Nephrol , vol.21 , pp. 1-15
- Brater, D.C.¹ Harris, C.² Redfern, J.S.³ Gertz, B.J.⁴

17
- 0025934766
- Nonsteroidal anti-inflammatory drugs: Effects on kidney function
- (1991) J Clin Pharmacol , vol.31 , pp. 588-598
- Whelton, A.¹ Hamilton, C.W.²

18
- 0028580588
- Do nonsteroidal anti-inflammatory drugs affect blood pressure? A meta-analysis
- (1994) Ann Intern Med , vol.121 , pp. 289-300
- Johnson, A.G.¹ Nguyen, T.V.² Day, R.O.³

19
- 0034041594
- Rofecoxib, a specific inhibitor of cyclooxygenase 2, with clinical efficacy comparable with that of diclofenac sodium: Results of a one-year, randomized, clinical trial in patients with osteoarthritis of the knee and hip
- (2000) Arthritis Rheum , vol.43 , pp. 978-987
- Cannon, G.W.¹ Caldwell, J.R.² Holt, P.³ Mclean, B.⁴ Seindenberg, B.⁵ Bolognese, J.⁶

20
- 0034717664
- A randomized trial of the efficacy and tolerability of the COX-2 inhibitor rofecoxib vs ibuprofen in patients with osteoarthritis
- (2000) Arch Intern Med , vol.160 , pp. 1781-1787
- Day, R.¹ Morrison, B.² Luza, A.³ Casteneda, O.⁴ Strusberg, A.⁵ Nahir, M.⁶

21
- 0035934070
- Risk of cardiovascular events associated with selective cox-2 inhibitors
- (2001) JAMA , vol.286 , pp. 954-959
- Mukherjee, D.¹ Nissen, S.E.² Topol, E.J.³

22
- 0000415311
- Ibuprofen, but not rofecoxib or acetaminophen, antagonizes the irreversible anti-platelet effect of aspirin
- (2000) Arthritis Rheum , vol.43 , Issue.SUPPL. 9
- Catella-Lawson, F.¹ Kapoor, S.C.² Reilly, M.P.³

23
- 0032948948
- Effects of specific inhibition of cyclooxygenase-2 on sodium balance, hemodynamics, and vasoactive eicosanoids
- (1999) J Pharmacol Exp Ther , vol.289 , pp. 735-741
- Catella-Lawson, F.¹ McAdam, B.² Morrison, B.W.³ Kapoor, S.⁴ Kujubu, D.⁵ Antes, L.⁶

24
- 0033524421
- Systemic biosynthesis of prostacyclin by cyclooxygenase (COX)-2: The human pharmacology of a selective inhibitor of COX-2
- (1999) Proc Natl Acad Sci USA , vol.96 , pp. 272-277
- McAdam, B.F.¹ Catella-Lawson, F.² Mardini, I.A.³ Kapoor, S.⁴ Lawson, J.A.⁵ FitzGerald, G.A.⁶

25
- 0035818601
- Cardiovascular thrombotic events in controlled, clinical trials of rofecoxib
- (2001) Circulation , vol.104 , pp. 1-9
- Konstam, M.A.¹ Weir, M.R.² Reicin, A.³

26
- 17744399021
- Tolerability profiles of rofecoxib (Vioxx) and Arthrotec
- (2001) Scand J Rheumatol , vol.30 , pp. 19-24
- Acevedo, E.¹ Castameda, P.² Ugaz, M.³ Beaulieu, A.D.⁴ Pons-Estel, B.⁵ Caeiro, F.⁶

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.